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Abstract
Background:  Murine myeloid leukemia (ML) provides a good animal model to study the
mechanisms of radiation-induced leukemia in humans. This disease has been cytogenetically
characterized by a partial deletion of chromosome 2 with G-banding. For the rapid diagnosis of ML,
this study reports a FISH method using spleen cells and peripheral blood smears from ML mice
exposed to gamma rays and neutrons with PU.1, a candidate ML tumor suppressor, as a probe.
Results: Among mice that were tentatively diagnosed with ML by clinical findings and blood smear
examination, 85% carried spleen cells showing the loss of PU.1 although the frequency of these
abnormal cells varied among individuals. Mice with very low frequencies of cells showing the loss
of one copy of PU.1 (one-PU.1 frequency) were later diagnosed pathologically not with ML but with
blastic or eosinophilic leukemia. Some neutron-irradiated mice had cells showing translocated
PU.1, although no pathological features differentiated these ML mice from ML mice expressing the
simple loss of PU.1.
The one-PU.1 frequency can be detected from spleen metaphase cells, spleen interphase cells, and
blood smears. There was a good correlation between the one-PU.1 frequency in spleen metaphase
cells and that in spleen interphase cells (r = 0.96) and between one-PU.1 frequency in spleen
interphase cells and that in blood cells (r = 0.83).
Conclusion: The FISH method was capable of detecting aberration of copy number of the PU.1
gene on murine chromosome 2, and using a peripheral blood smear is more practical and less
invasive than conventional pathological diagnosis or the cytogenetic examination of spleen cells.
Background
Murine myeloid leukemia (ML) provides a good animal
model to study the mechanisms of radiation-induced
leukemia in humans because it is thought to be similar to
the cancer type that has shown increased incidence among
atomic-bomb survivors [1]. This disease is cytogenetically
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characterized by a partial deletion of chromosome 2 [2-4].
Silver et al. [5] mapped the minimal deleted region to a
1.0 cM region homologous to human chromosome seg-
ment 11p11-12. Recently, the critical hematopoietic-spe-
cific transcription factor PU.1 (also known as SPI-1),
which is located within this region, is proposed as a ML
tumor suppressor [5-7].
It is very important for the diagnosis of murine ML to
check for aberrations on chromosome 2, as in the case of
Philadelphia chromosome for the diagnosis of human
ML. For this purpose, murine chromosomes are analyzed
using G-banding, Q-banding, and FISH techniques using
preparations of bone marrow or spleen cells. However, in
mice the time course of chromosomal changes cannot be
surveyed for individuals during radiation leukemogenesis
because mice must be killed for tissue sampling.
The present study attempted to detect the aberration on
murine chromosome 2 with a probe against the PU.1 gene
using peripheral blood smears, and compared these aber-
ration frequencies with those obtained from metaphase
and interphase cells isolated from spleens. As a result, the
frequency of cells showing the loss of one copy of PU.1
obtained by this method was very close to that from slides
prepared traditionally using spleen cells, and this new
method was useful for the rapid diagnosis of the detailed
classification of ML in living mice.
The validation of this method to diagnose murine ML is
discussed as well as its prospective application for the
diagnosis of human ML.
Results and discussion
Frequency of PU.1 abnormalities in radiation-induced ML 
mice
Interphase FISH analyses using PU.1 were performed
using spleen cells of ML-like mice that were sorted by clin-
ical findings and blood smear examination. Cells showing
the loss of one copy of the PU.1 gene due to the partial
deletion of chromosome 2 had 1 PU.1 signal (green) and
2 centromere signals (red), and were named G1R2 cells
(Fig. 1a,b). Among 11 gamma-irradiated ML-like mice
and 9 neutron-irradiated mice, 85% carried G1R2 cells,
which was consistent with the previous finding that more
than 90% of acute ML mice carry aberrations of chromo-
Spleen cells of radiation-induced myeloid leukemia mice observed by FISH using probes against PU.1 (green) and the centro- mere of chromosome 2 (red) Figure 1
Spleen cells of radiation-induced myeloid leukemia mice observed by FISH using probes against PU.1 (green) 
and the centromere of chromosome 2 (red). G1R2 cells with only one signal of PU.1 on chromosome 2 (a) and on 
another chromosome (b). Cells with 3 centromere signals suggested numerical abnormality (c).Molecular Cytogenetics 2008, 1:22 http://www.molecularcytogenetics.org/content/1/1/22
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some 2 [2,4,8]. In detail, 9 mice carried G1R2 cells among
11 gamma-irradiated ML-like mice, and 8 mice carried
G1R2 cells among 9 neutron-irradiated mice. Regarding
17 mice that carried G1R2 cells, the percentages of G1R2
cells among all cells examined varied from 54 to 100%.
Comparison of metaphase and interphase analyses of 
spleen cells
The results of FISH analysis were compared between met-
aphase and interphase cells for 7 gamma-irradiated ML-
like mice and 6 neutron-irradiated mice whose mitotic
indices were relatively high (Table 1). In 8 mice, all the
examined cells were G1R2 cells. One mouse (ID: c090)
exhibited that both copies of chromosome 2 were appar-
ently normal in all cells examined. In 4 other mice, mosa-
ics of normal and aberrant cells were observed.
Metaphase analysis of one mouse (ID: h061) showed that
one PU.1 signal was translocated in 60% of cells exam-
ined. Metaphase analysis of another mouse (ID: h121)
showed that both PU.1 signals were translocated in 10%
of cells, and one was translocated and the other was lost
in 90% of cells (Fig. 1b). In a further mouse (ID: j018),
60% of cells had 1 signal of PU.1 and 3 signals from the
centromere (Fig. 1c), suggesting a numerical abnormality.
These complex abnormalities were observed in neutron-
irradiated ML-like mice; however, no pathological fea-
tures of differentiated ML mice expressing complex abnor-
malities were identified from those expressing the simple
loss of one copy of PU.1.
As shown in Table 1, interphase FISH analysis data were
qualitatively consistent with metaphase data, and the fre-
quency of complex abnormalities might be higher in neu-
tron-irradiated mice than gamma-irradiated mice. In
general, metaphase FISH analysis provides more informa-
tion regarding complex chromosome aberrations than
interphase analysis so the latter cannot entirely replace the
former. In many cases, the mitotic indices of spleen cells
and bone marrow cells were considerably lower (less than
1%), which made metaphase analysis difficult. The com-
plex abnormalities of PU.1, which could be observed only
by metaphase analysis, did not show the relevance to
pathological features. To substitute for pathological diag-
nosis of ML, therefore, assessment for presence of G1R2
cells might be more important than the observation of
complexity of aberrations.
Frequency of cells with 1 PU.1 signal and 2 centromere 
signals
Next, metaphase and interphase analyses were compared
quantitatively. In this experiment, mice were diagnosed
with ML not only by clinical findings and blood smear
examination but also by flow cytometry and pathological
investigations to clarify the relation of frequency of G1R2
cells and clinical diagnosis. The percentages of G1R2 cells
varied from 0 to 100% (Fig. 2), but cells with 2 red and 0
green signals, i.e. with the loss of both PU.1 signals, were
not observed. There was a good correlation between the
percentage of cells with one PU.1 signal in the metaphase
and interphase specimens (r = 0.96), which suggested the
high reliability of the results obtained by interphase FISH.
Table 1: Cell distribution with aberration of PU.1 in the spleens of radiation-induced myeloid leukemia mice
No of metaphase cells with No of interphase cells with
2 PU.1 signals 1 PU.1 signal (1 deleted)
Mouse ID Exposure Both normal 1 trans -
located
2 trans -
located
1 normal 1 trans -
located
2 PU.1 signals 1 PU.1 signal 
(1 deleted)
b007 Gamma 1 0 0 19 0 1 19 Mosaic
b 0 2 1 G a m m a 0 0 01 40 0 5 0 A l l  G 1 R 2
b154 Gamma 0 0 0 18 0 2 48 Mosaic
c090 Gamma 15 0 0 0 0 50 0 All normal
d040 Gamma 0 0 0 9 0 0 50 All G1R2
e 0 3 6 G a m m a 0 0 02 00 0 5 0 A l l  G 1 R 2
e 1 2 7 G a m m a 0 0 02 00 0 5 0 A l l  G 1 R 2
h060 Neutron 0 0 0 7 0 0 50 All G1R2
h061 Neutron 0 12 0 8 0 23 27 Mosaic
h070 Neutron 0 0 0 7 0 0 50 All G1R2
h121 Neutron 0 0 2 0 18 9 41 Mosaic
h124 Neutron 0 0 0 20 0 0 50 All G1R2
j018 Neutron 0 0 0 8 0 0 20+30* All G1R2
*Cells with 1 signal of PU.1 and 3 centromere signalsMolecular Cytogenetics 2008, 1:22 http://www.molecularcytogenetics.org/content/1/1/22
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Among 17 mice, two showed very low frequencies of
G1R2 cells and very high WBC counts (about 2000 × 102/
μl). Later, the pathological examination indicated the pos-
sible diagnosis of blastic-type and eosinophilic leukemia.
The frequency of G1R2 cells in spleen cells may be a useful
marker to identify false-positive ML.
FISH data of peripheral blood smears
Interphase specimens from peripheral blood smears were
thicker than those from spleen cells due to the different
preparation methods so FISH signals were detected by Z-
stack function or by manually varying the focus (Fig. 3). It
was attempted to distinguish granulocytic cells from
erythroblasts, but this was found to be impossible. There
was a good correlation between the percentage of cells
with one signal of PU.1 in blood smears and that for inter-
phase spleen specimens (r = 0.83).
FISH analysis of a blood smear using PU.1 has good
potential as a method for the rapid diagnosis of ML that
was comparable to pathological diagnosis, but the latter is
time-consuming and labor intensive. Cells with the loss of
one copy of PU.1 can be counted the day after blood sam-
pling; blood smear preparation, FISH hybridization,
washing, and microscopic observation require 1 hour,
overnight, 3 hours, and a few hours, respectively. In addi-
tion, FISH analysis does not require cytogenetic skill or
highly-specialized equipment.
This technique can be useful for understanding radiation
leukemogenesis. The partial deletion of chromosome 2 by
radiation is suspected to be an initiating event of radiation
leukemogenesis [9]. FISH analysis using blood smears can
use living mice so that the time course of chromosomal
changes can be surveyed for individuals during leukemo-
genesis. In addition, in humans, the sampling of bone
marrow cells is painful for frail patients. Trials have been
started to clarify the clinical correlation of chromosome
changes in blood cells in chronic leukemia [10,11]. For
these cases, less invasive sampling for cytogenetic analysis
has advantages.
Conclusion
The FISH method for detecting aberrations of the PU.1
gene on murine chromosome 2 using peripheral blood
smears may be used as a rapid diagnostic method for the
Comparison of the frequency of cells with one signal of PU.1 and 2 signals of the centromere of chromosome 2 in radiation- induce myeloid leukemia mice Figure 2
Comparison of the frequency of cells with one signal of PU.1 and 2 signals of the centromere of chromosome 2 
in radiation-induce myeloid leukemia mice. Correlation between the frequency of cells showing a loss of one copy of 
PU.1 in spleen metaphase cells and that in spleen interphase cells (a) and between the frequencies in spleen interphase cells and 
that in blood cells (b). The some points were superimposed.Molecular Cytogenetics 2008, 1:22 http://www.molecularcytogenetics.org/content/1/1/22
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detailed classification of ML. This method is more practi-
cal and less invasive than conventional pathological diag-
nosis and for cytogenetic examination of spleen cells.
Methods
Animals
Male C3H mice were bred in the animal facility of the
National Institute of Radiological Sciences, Chiba, Japan.
They were housed in an air-conditioned room (23 ± 1°C)
with a relative humidity of 50 ± 5% under an alternating
12-h light/dark schedule (lights on at 7:00 a.m.). Mice
were fed a standard commercial laboratory diet and given
chlorinated water ad libitum. Mice received a dose of 3 Gy
of 137Cs γ-rays or neutrons generated from the NIRS cyclo-
tron, using the deuteron-beryllium reaction. The animals
were observed for their whole life span. When symptoms
of leukemia, such as a palpable spleen, wan palms, respi-
ratory distress, etc., became clear in the terminal stage of
the disease, the mice were anesthetized with diethyl ether
and tissues were sampled. ML-like mice were sorted by
histological examination of peripheral blood smears,
blood cell counts, and/or flow cytometric examination,
and the comprehensive diagnosis in each case was finally
established from histopathological investigations of tis-
sue/organs [12]. All animal experiments were carried out
with permission of and under regulation of the Institu-
tional Committee for Animal Safety and Welfare at our
institute. The smear preparations of peripheral blood were
made conventionally; one drop of blood was placed on a
clean slide, spread with another slide and dried.
Isolation of lymphocytes
The spleen cells were suspended mechanically in a dish
containing RPMI 1640 medium and filtered through a
100 μm nylon filter (BD Falcon, MA, USA). Except for
spleen cells for flow cytometry, cells were centrifuged,
resuspended in a 0.075 M KCl hypotonic solution with
0.025 μg/ml colcemid, kept at 37°C for 35 min, and then
fixed with methanol-acetic acid (3:1). Air-dried slides
were made in warm and humid conditions. The mitotic
indices of spleen cells were 0.5–1.5%.
The surface markers of spleen cells of some mice showing
symptoms of leukemia were analyzed by flow cytometry
using mouse monoclonal antibodies, and individuals
with positive cells for Mac-1 and Gr-1 in the spleen were
sorted as "ML mouse candidates".
Microscopic observation
FISH analysis of peripheral blood smears and spleen cells
was performed to identify deletions on chromosome 2.
When chromosome preparations of spleen cells were
compared with those of bone marrow cells; mitotic indi-
ces of the former and the latter were 1.15 ± 0.16% and
0.71 ± 0.11%, respectively (n = 14), and the chromo-
somes of spleen cells were easier to spread than those of
bone marrow cells. Hayata [13] reported that the percent-
age of leukemic cells among normal cells, the abnormal
chromosome number and the number of clones were
almost the same between spleens and bone marrow;
therefore, the present study analyzed chromosomes using
spleen samples not bone marrow samples. FISH probes
covering PU.1 and the centromere of chromosome 2 were
labeled directly with Spectrum Green and Spectrum
Orange (Vysis, Downers Grove, IL, USA), respectively
[14]. For FISH analysis, fresh peripheral blood smears
were fixed with methanol-acetic acid (3:1), dried, stored
at 4°C, and then treated with RNase just before hybridiza-
tion [15]. The slides were hybridized with probes follow-
ing the manufacturer's instructions. The slides were
counterstained with DAPI in Vectorshield mounting
medium (Vector Laboratories, Burlingame, CA, USA).
FISH analysis was performed for more than 30 cells in
each case by using an all-in-one type fluorescence micro-
scope BZ-8000 (Keyence Japan, Osaka, Japan). Cells with
2 red signals, i.e. having 2 centromeres of chromosome 2,
were mainly counted. For each case, more than 7 and 30
cells were scored for metaphase and interphase analysis,
respectively, according to the protocol of Yanagi et al.
[10].
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Blood smear specimen of radiation-induced myeloid leuke- mia mice observed by FISH using probes against PU.1 (green)  and the centromere of chromosome 2 (red) Figure 3
Blood smear specimen of radiation-induced myeloid 
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against PU.1 (green) and the centromere of chromo-
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